Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ocular surface disease associated with dupilumab treatment for atopic diseases
Canan Aslı Utine, Gavin Li, Penny A. Asbell, et al.
The Ocular Surface (2020) Vol. 19, pp. 151-156
Closed Access | Times Cited: 37

Showing 26-50 of 37 citing articles:

Practical Management of Patients with Atopic Dermatitis on Dupilumab
Kim Papp, Chih-ho Hong, M. Perla Lansang, et al.
Dermatology and Therapy (2021) Vol. 11, Iss. 5, pp. 1805-1828
Open Access | Times Cited: 6
Dupilumab-induced ocular surface disease: a primer
Merin Anna Reji, Aaisha Haque, Supriya Goyal, et al.
BMJ Case Reports (2022) Vol. 15, Iss. 4, pp. e249019-e249019
Open Access | Times Cited: 4
A rare case of vernal keratoconjunctivitis in a patient with atopic dermatitis treated with tralokinumab
Belinda Lai, Kevin Phan, N. Lewis, et al.
Journal of the European Academy of Dermatology and Venereology (2021) Vol. 36, Iss. 5
Closed Access | Times Cited: 5
Canalicular stenosis associated with dupilumab treatment for atopic dermatitis
Lotte Loret, Virginie Ninclaus, Amélie Dendooven, et al.
European Journal of Dermatology (2021) Vol. 31, Iss. 6, pp. 843-844
Closed Access | Times Cited: 4
Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective
Alba Guglielmo, Maria Ludovica Deotto, Luigi Naldi, et al.
Dermatology Reports (2023)
Open Access | Times Cited: 1
Dermatoses of the Eye, Eyelids and Eyebrows
Valerie Saw, S. N. Cohen
(2024), pp. 1-55
Closed Access
Dupilumab-induced ocular surface disease: a primer
Merin Anna Reji, Aaisha Haque, Supriya Goyal, et al.
Drug and Therapeutics Bulletin (2023) Vol. 62, Iss. 2, pp. 27-31
Closed Access
Okuläre Nebenwirkungen von Dupilumab – Übersichtsarbeit und Therapieempfehlung der „Kommission für Trockenes Auge und Oberflächenerkrankungen“ der Österreichischen Ophthalmologischen Gesellschaft (ÖOG)
Nora Woltsche, Julia Aschauer, Ingrid Boldin, et al.
Spektrum der Augenheilkunde (2023) Vol. 37, Iss. 5, pp. 131-137
Open Access
Staying ahead of dupilumab-associated ocular surface disease
Patricia-Ann Laughrea, Mélanie Hébert
Canadian Eye Care Today (2022)
Open Access
Patient profiling and prediction of response to immune-modulating treatment in moderate-to-severe atopic dermatitis
Daphne S. Bakker
(2021)
Open Access
Comment on: ‘Dupilumab-associated ocular surface disease: presentation, management and long-term sequelae’
Tomoyuki Kawada
Eye (2021) Vol. 36, Iss. 7, pp. 1515-1515
Open Access
Response to: 'Comment on: ‘Dupilumab-associated ocular surface disease: presentation, management and long-term sequelae’'
Magdalena Popiela, Michael R. Ardern‐Jones, Parwez Hossain
Eye (2021) Vol. 36, Iss. 7, pp. 1516-1516
Open Access
Previous Page - Page 2

Scroll to top